IL309447A - Pharmaceutical preparations of epidermal growth factor receptor inhibitor - Google Patents

Pharmaceutical preparations of epidermal growth factor receptor inhibitor

Info

Publication number
IL309447A
IL309447A IL309447A IL30944723A IL309447A IL 309447 A IL309447 A IL 309447A IL 309447 A IL309447 A IL 309447A IL 30944723 A IL30944723 A IL 30944723A IL 309447 A IL309447 A IL 309447A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
growth factor
factor receptor
epidermal growth
receptor inhibitor
Prior art date
Application number
IL309447A
Other languages
English (en)
Hebrew (he)
Inventor
Caitlin N Kinkema
Debra L Mazaik
Clare Aubrey Medendorp
Onkar Shripad Vaze
Original Assignee
Blueprint Medicines Corp
Caitlin N Kinkema
Debra L Mazaik
Clare Aubrey Medendorp
Onkar Shripad Vaze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blueprint Medicines Corp, Caitlin N Kinkema, Debra L Mazaik, Clare Aubrey Medendorp, Onkar Shripad Vaze filed Critical Blueprint Medicines Corp
Publication of IL309447A publication Critical patent/IL309447A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL309447A 2021-06-23 2022-06-22 Pharmaceutical preparations of epidermal growth factor receptor inhibitor IL309447A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163214099P 2021-06-23 2021-06-23
PCT/US2022/034433 WO2022271765A1 (en) 2021-06-23 2022-06-22 Pharmaceutical compositions of an epidermal growth factor receptor inhibitor

Publications (1)

Publication Number Publication Date
IL309447A true IL309447A (en) 2024-02-01

Family

ID=82608194

Family Applications (1)

Application Number Title Priority Date Filing Date
IL309447A IL309447A (en) 2021-06-23 2022-06-22 Pharmaceutical preparations of epidermal growth factor receptor inhibitor

Country Status (9)

Country Link
US (1) US20240293323A1 (cg-RX-API-DMAC7.html)
EP (1) EP4358942A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024525206A (cg-RX-API-DMAC7.html)
CN (1) CN117835970A (cg-RX-API-DMAC7.html)
AR (1) AR126195A1 (cg-RX-API-DMAC7.html)
CA (1) CA3223889A1 (cg-RX-API-DMAC7.html)
IL (1) IL309447A (cg-RX-API-DMAC7.html)
TW (1) TW202317120A (cg-RX-API-DMAC7.html)
WO (1) WO2022271765A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024523506A (ja) * 2021-06-23 2024-06-28 ブループリント メディシンズ コーポレイション 上皮成長因子受容体阻害剤の塩及び結晶形態
CN116554150B (zh) * 2022-12-30 2025-12-19 苏州浦合医药科技有限公司 第四代egfr抑制剂
WO2024249660A1 (en) * 2023-05-31 2024-12-05 Amgen Inc. Compositions comprising sotorasib

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100297194A1 (en) * 2009-04-30 2010-11-25 Nathaniel Catron Formulation for oral administration of apoptosis promoter
WO2015152433A1 (en) * 2014-03-31 2015-10-08 Hanmi Pharm. Co., Ltd. Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same
KR102498693B1 (ko) * 2016-09-07 2023-02-10 셀진 코포레이션 정제 조성물
JP2024523506A (ja) * 2021-06-23 2024-06-28 ブループリント メディシンズ コーポレイション 上皮成長因子受容体阻害剤の塩及び結晶形態

Also Published As

Publication number Publication date
WO2022271765A1 (en) 2022-12-29
TW202317120A (zh) 2023-05-01
EP4358942A1 (en) 2024-05-01
CN117835970A (zh) 2024-04-05
CA3223889A1 (en) 2022-12-29
JP2024525206A (ja) 2024-07-10
US20240293323A1 (en) 2024-09-05
AR126195A1 (es) 2023-09-27

Similar Documents

Publication Publication Date Title
EP4076395A4 (en) INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CGRP INHIBITORS
LT4146348T (lt) Nek7 kinazės inhibitoriai
IL320739A (en) rock2 inhibitors
EP3969442A4 (en) Inhibitors of fibroblast growth factor receptor kinases
IL326424A (en) Pharmaceutical compounds and compositions as c-kit kinase inhibitors
IL316616A (en) ROCK2 inhibitors
IL313548A (en) MET kinase inhibitors
HUE068818T2 (hu) Transzglutamináz inhibitorok
IL314397A (en) CDK4/6 kinase inhibitors
IL314824A (en) Combination formulation of sedazuridine
PL4192814T3 (pl) Inhibitory transglutaminaz
IL325596A (en) Pharmaceutical preparations for NEK7 kinase inhibitors
LT4192812T (lt) Transgliutaminazės inhibitoriai
PL4062913T3 (pl) Stały preparat doustny utidelonu
SG10201909596RA (en) Synthesis of Tyrosine Kinase Inhibitors
EP4370117A4 (en) PHARMACEUTICAL COMPOSITIONS OF OZANIMOD
CA3297265A1 (en) Pharmaceutical compositions for inhibitors of nek7 kinase
HK40082084A (en) Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5
GB202203181D0 (en) Inhibitors of elF4A
GB202107612D0 (en) Inhibitors of metallo-beta-lactamases
HK40118888A (en) Inhibitors of met kinase
HK40086963A (en) Inhibitors of sarm1
HK40110997A (en) Pharmaceutical compositions of efruxifermin
IL317760A (en) History of benzocarbazoles as DRP1 inhibitors
HK40075448A (en) Inhibitors of sarm1